Aastrom Biosciences, Inc.
Dominos Farms Lobby K
24 Frank Lloyd Wright Drive
Ann Arbor,
MI 48105
United States - Map
Phone: 734-930-5555
Fax: 734-665-0485
Web Site: http://www.aastrom.com
| Aastrom Biosciences, Inc. engages in developing autologous cell products for the treatment of severe, chronic, and cardiovascular diseases. The company's proprietary tissue repair cell (TRC) technology expands the numbers of stem and early progenitor cells from a small amount of bone marrow collected from the patient. The company is conducting a Phase II cardiac regeneration clinical trial (the IMPACT-DCM trial) in patients with dilated cardiomyopathy (DCM severe chronic heart failure) and a Phase IIb vascular regeneration clinical trial (the RESTORE-CLI trial) in patients with critical limb ischemia (CLI the most severe form of peripheral arterial disease). Aastrom Biosciences would also initiate its U.S. Phase II clinical trial to evaluate the catheter delivery of CRCs for the treatment of DCM. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Timothy M. Mayleben , 49
Chief Exec. Officer, Pres, Chief Financial Officer |
$
44.00K | N/A | Dr. Ronnda L. Bartel Ph.D., 51
VP of Technical Operations |
N/A
| N/A | Ms. Julie A. Caudill ,
Corp. Sec. and Controller |
N/A
| N/A | Mr. Kris M. Maly ,
Sr. Director of Communications & Admin. |
N/A
| N/A | Mr. Sheldon A. Schaffer Ph.D., 66
VP of Corp. Devel. and Intellectual Property |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.52% Nasdaq 0.00%
Profile
